FDA-Compliant Pharmaceutical Manufacturing (Antibiotic Injectable)

This contract involves the manufacture of Clindamycin Phosphate Injection, USP, ensuring strict compliance with FDA, DLA, and military specifications. The scope encompasses production of sterile injectable pharmaceuticals with rigorous batch testing, quality assurance procedures, and complete documentation to meet regulatory and defense requirements. The contract is a subcontract opportunity under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The contracting agency is the Department of Defense's Medical Supply Chain Pharmacy Field Support Activity, with the place of performance listed as FPO, ZIP code 96607. The contract was posted on May 31, 2026, with responses due by June 8, 2026. It focuses on delivering high-quality antibiotic injectables to support defense medical supply chains, ensuring all manufacturing processes adhere to the necessary sterility and pharmaceutical standards for injectable drugs.